A Randomised Controlled Trial Comparing Two-Dose Priming With the 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks to 6 and 14 Weeks in Nepali Children
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 13 Oct 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.
- 06 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Mar 2015 New trial record